Odiparcil (Standard)
Odiparcil (Standard) is the analytical standard of Odiparcil (HY-10277). This product is intended for research and analytical applications. Odiparcil (SB-424323) is an orally active β-D-xyloside derivative. Odiparcil can effectively divert the synthesis of cellular glycosaminoglycans (GAG) into secreted soluble species and reduce GAG accumulation. Odiparcil shows antithrombin and antiplatelet activity. Odiparcil can be used for the researches of metabolic and cardiovascular disease, such as mucopolysaccharidoses (MPS) and thrombosis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 137215-12-4
- 分子式: C15H16O6S
- 分子量:324.35
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
化学情報
- 純度とドキュメンテーション
-
Help & FAQs
-
HY-10277
Odiparcilβ-D-xyloside Derivative -
HY-10787
XimelagatranThrombin Inhibitor -
HY-B0375
ArgatrobanThrombin Inhibitor -
HY-10163
DabigatranThrombin Inhibitor -
HY-10274A
Dabigatran etexilate mesylateAntithrombotic Agent -
HY-B0375A
Argatroban monohydrateThrombin Inhibitor -
HY-10163R
Dabigatran (Standard)Thrombin Inhibitor -
HY-129056
MelagatranThrombin Inhibitor -
HY-10274
Dabigatran etexilateAntithrombotic Agent -
HY-B0375R
Argatroban (Standard)Thrombin Inhibitor -
HY-B0209
MetolazoneDiuretics -
HY-P1000
TRAP-14Thrombin Receptor Agonist
Product Information
説明
アプリケーション
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
化学情報
-
CAS 番号 137215-12-4
-
分子量 324.35
-
分子式 C15H16O6S
-
SMILES
CC(C1=CC=C(O[C@H]2[C@@H]([C@H]([C@@H](CS2)O)O)O)C=C1O3)=CC3=O
-
別名
SB-424323 (Standard)
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Entchev E, et al. Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models. PLoS One. 2020 May 15;15(5):e0233032. [Content Brief]
[2]. Toomey JR, et al. A comparison of the beta-D-xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. J Thromb Haemost. 2006 Sep;4(9):1989-96. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Odiparcil (Standard) 関連分類
HY-10277R 関連分類
Powered by Bioz